The sooner analyze (31) (N=fifty six patients) observed higher levels of retrospectively assessed acute worry disorder indicators and latest PTSD signs amid patients who obtained enantiomer esketamine, compared with individuals that been given racemic ketamine or opioids; the racemic ketamine group also showed mildly elevated acute strain disorder